CD44++/CD24−− Cells Are Transit Progenitors and Do Not Determine the Molecular Subtypes and Clinical Parameters in Breast Carcinomas

Author： Lüü Xinquan   Xu Kejia   Lüü Huiyan   Yin Yuhui   Ma Changlu   Liu Yishan   Li Huixiang   Suo Zhenhe  

Publisher： Informa Healthcare

ISSN： 1521-0758

Source： Ultrastructural Pathology, Vol.35, Iss.2, 2011-04, pp. : 72-78

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Epithelial mesenchymal transition correlates with CD24+CD44+ and CD133+ cells in pancreatic cancer

By                      

Oncology Reports, Vol. 27, Iss. 5, 2012-01 ,pp. : 1599-1605

Spandidos Publications

Access to resources Recommend Favorite

Clinical implications of Ezrin and CD44 coexpression in breast cancer

By    

Oncology Reports, Vol. 30, Iss. 4, 2013-01 ,pp. : 1899-1905

Spandidos Publications

Access to resources Recommend Favorite

A CD44−/CD24+ phenotype is a poor prognostic marker in early invasive breast cancer

By Ahmed Mohamed   Aleskandarany Mohammed   Rakha Emad   Moustafa Radwa   Benhasouna Ahmed   Nolan Christopher   Green Andrew   Ilyas Mohammad   Ellis Ian  

Breast Cancer Research and Treatment, Vol. 133, Iss. 3, 2012-06 ,pp. : 979-995

Springer Publishing Company

Access to resources Recommend Favorite

The role of CD44+/CD24-/low biomarker for screening, diagnosis and monitoring of breast cancer

By                  

Oncology Reports, Vol. 31, Iss. 3, 2014-01 ,pp. : 1127-1132

Spandidos Publications

Access to resources Recommend Favorite

Inhibition of Cdk2 kinase activity selectively targets the CD44+/CD24-/Low stem-like subpopulation and restores chemosensitivity of SUM149PT triple-negative breast cancer cells

By                      

International Journal of Oncology, Vol. 45, Iss. 3, 2014-01 ,pp. : 1193-1199

Spandidos Publications

Access to resources Recommend Favorite